Issues
-
Cover Image
Cover Image
Oral administration of BSA-FITC-loaded polylactic acid microparticles (green) prepared via phase inversion nanoencapsulation (PIN) resulted in rapid uptake (within 15 minutes) and persistence (for at least 24 hours) in the Peyer's patches (PP) of 10 week-old APCmin/+ mice (magenta, dendritic cells; blue, B-cells). Uptake in the PP was followed by trafficking of the particles to the mesenteric lymph nodes. Particles could not be visualized in the villi or the enterocytes of the small intestine or in the colon. Oral IL-10 PIN particles ameliorated intestinal polyposis and systemic symptoms of disease in the APCmin/+ mice via neutralization of CD4+Foxp3+RORγt+IL-17+ pathogenic T-regulatory cells found in the immune structures of the gastrointestinal tract. For details, see article by Chung and colleagues on page 5377. - PDF Icon PDF LinkTable of Contents
Cancer Research
Table of Contents
Breaking Advances
Review
Meeting Report
Biomimetic Tissue–Engineered Systems for Advancing Cancer Research: NCI Strategic Workshop Report
Priority Reports
Oral Interleukin-10 Alleviates Polyposis via Neutralization of Pathogenic T-Regulatory Cells
Integrated Systems and Technologies
Microenvironment and Immunology
Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
Molecular and Cellular Pathobiology
CDC42 Inhibition Suppresses Progression of Incipient Intestinal Tumors
Prevention and Epidemiology
Therapeutics, Targets, and Chemical Biology
Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells
Tumor and Stem Cell Biology
A Comprehensive DNA Methylation Profile of Epithelial-to-Mesenchymal Transition
Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer
Correction
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.